한글목차

마이크로니들 약물전달 시스템 시장 규모는 2025년 73억 7,000만 달러에서 2034년에는 147억 7,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 8.04%로 성장할 전망입니다.

마이크로니들 약물전달 시스템 시장은 무통의 효율적인 약물 투여 방법에 대한 수요 증가를 배경으로 괄목할만한 성장을 거듭하고 있습니다. 마이크로니들은 기존 주사 기술에 비해 침습성이 낮고, 피하주사 바늘에 따른 불편함 없이 백신, 생물학적 제제, 저분자 화합물을 피부로 전달할 수 있습니다. 만성질환의 증가, 약물 자가투여에 대한 니즈, 환자 순응도에 대한 중요성이 높아지면서 마이크로니들 기술의 채택이 증가하고 있습니다. 마이크로니들 디자인, 재료 및 제조 공정의 혁신은 이러한 전달 시스템의 효과와 안전성을 향상시켜 의료 제공자와 환자 모두에게 더욱 매력적으로 다가갈 수 있도록 하고 있습니다.

또한, 특히 세계 보건 이니셔티브에서 백신 투여에 대한 관심이 높아지면서 마이크로니들 약물전달 시스템 시장에 영향을 미치고 있습니다. 효율적이고 확장 가능한 백신 투여 방법에 대한 수요가 증가함에 따라, 마이크로니들은 예방접종률을 높이고 의료시스템의 부담을 줄일 수 있는 효과적인 솔루션으로 검토되고 있습니다. 또한, 웨어러블 기기 및 디지털 헬스 플랫폼과 같은 스마트 기술과의 통합으로 마이크로니들 시스템의 적용 범위가 확대되어 시장 성장을 촉진하고 있습니다.

또한, 약물전달 기술에 대한 연구개발에 대한 집중도가 높아짐에 따라 마이크로니들 시장의 혁신이 촉진되고 있습니다. 제약회사, 연구기관, 기술 개발자 간의 협력은 마이크로니들 제제 기술 및 응용 분야의 발전을 주도하고 새로운 제품이 의료 환경의 진화하는 요구에 부응할 수 있도록 보장합니다. 마이크로니들 약물전달 시스템의 장점에 대한 소비자 및 의료 종사자들의 인식이 높아진 것도 시장 확대에 기여하고 있습니다. 요약하면, 마이크로니들 약물전달 시스템 시장은 기술 발전, 환자 중심 솔루션에 대한 집중, 약물 투여 방법 개선에 대한 노력으로 인해 견조한 성장이 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 마이크로니들 약물전달 시스템 시장 : 유형별

제5장 세계의 마이크로니들 약물전달 시스템 시장 : 소재별

제6장 세계의 마이크로니들 약물전달 시스템 시장 : 용도별

제7장 세계의 마이크로니들 약물전달 시스템 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Microneedle Drug Delivery Systems Market size is expected to reach USD 14.77 Billion in 2034 from USD 7.37 Billion (2025) growing at a CAGR of 8.04% during 2026-2034.

The microneedle drug delivery systems market is experiencing significant growth, driven by the increasing demand for painless and efficient drug administration methods. Microneedles offer a minimally invasive alternative to traditional injection techniques, allowing for the delivery of vaccines, biologics, and small molecules through the skin without the discomfort associated with hypodermic needles. The rise in chronic diseases, the need for self-administration of medications, and the growing emphasis on patient compliance are propelling the adoption of microneedle technologies. Innovations in microneedle design, materials, and manufacturing processes are enhancing the effectiveness and safety of these delivery systems, making them more appealing to both healthcare providers and patients.

Moreover, the increasing focus on vaccine delivery, particularly in the context of global health initiatives, is influencing the microneedle drug delivery systems market. As the demand for efficient and scalable vaccine administration methods rises, microneedles are being explored as a viable solution for enhancing immunization coverage and reducing the burden on healthcare systems. Additionally, the integration of microneedle systems with smart technologies, such as wearable devices and digital health platforms, is expanding their applications and driving market growth.

Furthermore, the growing emphasis on research and development in drug delivery technologies is fostering innovation in the microneedle market. Collaborations between pharmaceutical companies, research institutions, and technology developers are driving advancements in microneedle formulations and applications, ensuring that new products meet the evolving needs of the healthcare landscape. The increasing awareness of the benefits of microneedle drug delivery systems among consumers and healthcare professionals is also contributing to market expansion. In summary, the microneedle drug delivery systems market is set for robust growth, characterized by technological advancements, a focus on patient-centric solutions, and a commitment to improving drug administration methods.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Solid
• Hollow
• Dissolving
• Coated
• Others

By Material

• Silicon
• Metal
• Polymer
• Others

By Application

• Dermatology
• Drug Delivery
• Pain Management
• Cancer Therapy
• Vaccine Delivery
• Others

COMPANIES PROFILED

• Raphas, Novartis International AG, Becton Dickinson and Company, B Braun, NanoPass technologies limited, Termo, Smiths Medical, Cardinal Health, 3M

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Solid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hollow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Dissolving Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Coated Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Silicon Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Metal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Polymer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cancer Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Vaccine Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Material
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Material
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Material
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Material
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Material
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL MICRONEEDLE DRUG DELIVERY SYSTEMS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Raphas
  • 9.2.2 Novartis International AG
  • 9.2.3 Becton Dickinson And Company
  • 9.2.4 B. Braun
  • 9.2.5 NanoPass Technologies Limited
  • 9.2.6 Termo
  • 9.2.7 Smiths Medical
  • 9.2.8 Cardinal Health
  • 9.2.9 3M